BioCentury | Aug 19, 2015
Company News

Management tracks

Anemia and asthma play Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) named Louis Matis SVP and chief development officer. Matis was executive director of strategic evaluation at Alexion Pharmaceuticals Inc. (NASDAQ:ALXN). Cardiovascular company Armetheon Inc. (Milpitas, Calif.) named...
BioCentury | May 26, 2014
Clinical News

CLP-1001: Completed Phase IIb enrollment

Sorbent completed enrollment of 275 patients with signs and symptoms of fluid overload following a recent heart failure-related hospitalization in the double-blind, placebo-controlled, U.S. Phase IIb STEPWISE trial evaluating twice daily 15 g CLP-1001. The...
BioCentury | May 26, 2014
Financial News

Sorbent completes venture financing

Sorbent Therapeutics Inc. , Sunnyvale, Calif. Business: Renal, Cardiovascular Date completed: 5/15/14 Type: Venture financing Raised: $6.5 million Investors: CMEA Capital; Arch Venture Partners; Sofinnova Ventures; AgeChem Venture Fund; Novartis Venture Funds Note: Sorbent raised $6.5...
BioCentury | Feb 3, 2014
Company News

Sorbent management update

Sorbent Therapeutics Inc. , Sunnyvale, Calif. Business: Renal, Cardiovascular Hired: Tom O'Neil as CFO, formerly VP of finance and administration at ChemGenex Pharmaceuticals Ltd. , which Cephalon Inc. acquired; Teva Pharmaceutical Industries Ltd. subsequently acquired Cephalon WIR...
BioCentury | Apr 15, 2013
Clinical News

CLP-1001: Phase IIb started

Sorbent began the double-blind, placebo-controlled, U.S. Phase IIb STEPWISE trial to evaluate twice daily 15 g CLP-1001 in about 250 patients with signs and symptoms of fluid overload following a recent heart failure-related hospitalization. Last...
BioCentury | Dec 10, 2012
Company News

Sorbent management update

Sorbent Therapeutics Inc. , Sunnyvale, Calif. Business: Renal, Cardiovascular Hired: Jason Levin as CBO, a newly created position, formerly CBO of BrainCells Inc. WIR Staff...
BioCentury | Jun 18, 2012
Clinical News

CLP-1001: Phase IIa data

A double-blind Phase IIa trial in 111 heart failure patients with CKD showed that CLP-1001 for 8 weeks significantly improved functional heart capacity as measured by the proportion of patients who achieved an improvement of...
BioCentury | Apr 23, 2012
Company News

Sorbent board of directors update

Sorbent Therapeutics Inc. , Sunnyvale, Calif. Business: Renal, Cardiovascular Appointed: Randall Woods, formerly president and CEO of NovaCardia Inc. , which Merck & Co. Inc. acquired, as chairman WIR Staff Cardiovascular Renal...
BioCentury | Apr 23, 2012
Company News

Sorbent management update

Sorbent Therapeutics Inc. , Sunnyvale, Calif. Business: Renal, Cardiovascular Hired: Howard Dittrich as CMO, a newly created position, formerly CMO of Sequel Pharmaceuticals Inc. WIR Staff...
BioCentury | Jul 4, 2011
Company News

Sorbent board of directors update

Sorbent Therapeutics Inc. , Sunnyvale, Calif. Business: Renal, Cardiovascular Appointed: Markus Goebel, managing director at Novartis Venture Funds WIR Staff...
Items per page:
1 - 10 of 15
BioCentury | Aug 19, 2015
Company News

Management tracks

Anemia and asthma play Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) named Louis Matis SVP and chief development officer. Matis was executive director of strategic evaluation at Alexion Pharmaceuticals Inc. (NASDAQ:ALXN). Cardiovascular company Armetheon Inc. (Milpitas, Calif.) named...
BioCentury | May 26, 2014
Clinical News

CLP-1001: Completed Phase IIb enrollment

Sorbent completed enrollment of 275 patients with signs and symptoms of fluid overload following a recent heart failure-related hospitalization in the double-blind, placebo-controlled, U.S. Phase IIb STEPWISE trial evaluating twice daily 15 g CLP-1001. The...
BioCentury | May 26, 2014
Financial News

Sorbent completes venture financing

Sorbent Therapeutics Inc. , Sunnyvale, Calif. Business: Renal, Cardiovascular Date completed: 5/15/14 Type: Venture financing Raised: $6.5 million Investors: CMEA Capital; Arch Venture Partners; Sofinnova Ventures; AgeChem Venture Fund; Novartis Venture Funds Note: Sorbent raised $6.5...
BioCentury | Feb 3, 2014
Company News

Sorbent management update

Sorbent Therapeutics Inc. , Sunnyvale, Calif. Business: Renal, Cardiovascular Hired: Tom O'Neil as CFO, formerly VP of finance and administration at ChemGenex Pharmaceuticals Ltd. , which Cephalon Inc. acquired; Teva Pharmaceutical Industries Ltd. subsequently acquired Cephalon WIR...
BioCentury | Apr 15, 2013
Clinical News

CLP-1001: Phase IIb started

Sorbent began the double-blind, placebo-controlled, U.S. Phase IIb STEPWISE trial to evaluate twice daily 15 g CLP-1001 in about 250 patients with signs and symptoms of fluid overload following a recent heart failure-related hospitalization. Last...
BioCentury | Dec 10, 2012
Company News

Sorbent management update

Sorbent Therapeutics Inc. , Sunnyvale, Calif. Business: Renal, Cardiovascular Hired: Jason Levin as CBO, a newly created position, formerly CBO of BrainCells Inc. WIR Staff...
BioCentury | Jun 18, 2012
Clinical News

CLP-1001: Phase IIa data

A double-blind Phase IIa trial in 111 heart failure patients with CKD showed that CLP-1001 for 8 weeks significantly improved functional heart capacity as measured by the proportion of patients who achieved an improvement of...
BioCentury | Apr 23, 2012
Company News

Sorbent board of directors update

Sorbent Therapeutics Inc. , Sunnyvale, Calif. Business: Renal, Cardiovascular Appointed: Randall Woods, formerly president and CEO of NovaCardia Inc. , which Merck & Co. Inc. acquired, as chairman WIR Staff Cardiovascular Renal...
BioCentury | Apr 23, 2012
Company News

Sorbent management update

Sorbent Therapeutics Inc. , Sunnyvale, Calif. Business: Renal, Cardiovascular Hired: Howard Dittrich as CMO, a newly created position, formerly CMO of Sequel Pharmaceuticals Inc. WIR Staff...
BioCentury | Jul 4, 2011
Company News

Sorbent board of directors update

Sorbent Therapeutics Inc. , Sunnyvale, Calif. Business: Renal, Cardiovascular Appointed: Markus Goebel, managing director at Novartis Venture Funds WIR Staff...
Items per page:
1 - 10 of 15